EADV: EADV 2018: first real-life data from studies of atopic dermatitis patients on Dupilumab
The first data on real-life adult atopic dermatitis patients being treated with Sanofi and Regeneron's dupilumab was revealed at the...Read More...The post EADV 2018: first real-life data from studies of atopic dermatitis patients on Dupilumab appeared first on Pharmaceutical Technology.
Read full article »
CEO
EADV's headquarters is located in lugano, Ticino. EADV generates $39.4K in revenue per employee EADV has 1 followers on Owler.